An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of Baltimore
Luis A Gonzalez Corro(Johns Hopkins University), Gregory M. Lucas(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Amanda Rosecrans(Johns Hopkins University), Miles Landry(Johns Hopkins University), Katie Zook(Johns Hopkins University), Darrell J. Gaskin(Johns Hopkins University), Robert S. Harris(Johns Hopkins University), Kathleen R. Page(Johns Hopkins University)
Cited by 11
Related Papers
The Economic Costs of Pain in the United States
|Journal of Pain|2012|2.4k
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Estimating the Economic Burden of Racial Health Inequalities in the United States
|International Journal of Health Services|2011|380